Behind-the-knee pain could be due to muscle strain or arthritis—or something far more serious. Orthopedic experts say these ...

Most states allow some form of "medical marijuana." It is especially popular with pain patients, many of whom do not have ...

Globus Medical (NYSE:GMED) announced today that it agreed to acquire chronic pain treatment developer Nevro (NYSE:NVRO).

Northwestern Medicine is a global leader in clinical trial research, including spineCLARITY is a randomized study designed to demonstrate ...

Journave, the first non-addictive opioid-like pain medication, was developed based on Yale research from the ’90s.

Irritable bowel syndrome (IBS) is a common digestive disorder with unclear causes, affecting about 10% of the global population. Researchers have now discovered that opioid delta-receptor agonists may ...

As shares of Boston-based Vertex shot higher on the news of its non-opioid pill, Journavx, we took a look at investment in ...

Adolore BioTherapeutics (”Adolore” or the “Company”), is developing intracellularly-delivered neuromodulators that naturally reduce neuronal excitability to restore balance to the PNS/CNS to treat the ...

Federal officials have approved a new type of pain pill designed to eliminate the risks of addiction and overdose associated with opioid medications like Vicodin and OxyContin. The U.S.

The Phase IIa results continue a surge of momentum in a treatment space that last week saw the approval of Vertex’s Journavx ...

Students Offering Optimism to Help, or SOOTHE, gives companionship to patients while teaching future doctors about the human side of medicine ...

During “Real Possibilities with AARP Michigan,” Dr. Joshua P. June from the Great Lakes Center of Rheumatology shares tips ...